Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats
Background The present study was designed to evaluate serum lipid profile and tumor necrosis factor-alpha (TNF-ɑ) level in diabetic rats at implantation time. Type 2 diabetes mellitus (T2DM) could affect various systems, including innate immune system and it causes chronic low-grade inflammation, in...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Royan Institute (ACECR), Tehran
2019-07-01
|
Series: | International Journal of Fertility and Sterility |
Subjects: | |
Online Access: | http://www.ijfs.ir/article_45540_1cd34349c0ba8a4d26e56eecb65ff422.pdf |
_version_ | 1818403624175271936 |
---|---|
author | Abbas Bakhteyari Parvaneh Nikpour Fatemah Sadat Mostafavi Nahid Eskandari Mohammad Matinfar Sara Soleimani Asl Roshanak Aboutorabi |
author_facet | Abbas Bakhteyari Parvaneh Nikpour Fatemah Sadat Mostafavi Nahid Eskandari Mohammad Matinfar Sara Soleimani Asl Roshanak Aboutorabi |
author_sort | Abbas Bakhteyari |
collection | DOAJ |
description | Background The present study was designed to evaluate serum lipid profile and tumor necrosis factor-alpha (TNF-ɑ) level in diabetic rats at implantation time. Type 2 diabetes mellitus (T2DM) could affect various systems, including innate immune system and it causes chronic low-grade inflammation, increasing level of TNF-ɑ. Furthermore, T2DM is often accompanied by impaired lipid profile. Metformin and pioglitazone are used as the first and second lines of treatment for T2DM. Materials and Methods In this experimental study, 35 adult virgin female wistar rats, weighting 175-225 g, were randomly categorized into five groups: i. Control, ii. Sham, iii. Nicotinamide (NA)+streptozotocin (STZ) induced T2DM, iv. Diabetic+pioglitazone (20 mg/kg/day for 28 days oral administration), and v. Diabetic+metformin (100 mg/kg/day for 28 days oral administration). At the time of implantation, TNF-ɑ level in serum of rats was measured by ELISA kit. Glucose was measured using photometric method and lipid profiles were calculated by enzymatic methods. Results Level of TNF-ɑ in the diabetic group was significantly higher than other groups (P < 0.001). In metformin treated group, TNF-ɑ serum level was also significantly higher than pioglitazone treated group (P < 0.001). Fasting blood sugar (FBS) and lipid profiles were significantly higher in diabetic group. Conclusion Metformin and pioglitazone have similar effects on glucose, lipid profiles and TNF-ɑ serum levels. Among these drugs, pioglitazone has more efficient influence on TNF-α serum level, in comparison with metformin. |
first_indexed | 2024-12-14T08:27:13Z |
format | Article |
id | doaj.art-b96b1ee803b8463d9af2d4abbcf6a498 |
institution | Directory Open Access Journal |
issn | 2008-076X 2008-0778 |
language | English |
last_indexed | 2024-12-14T08:27:13Z |
publishDate | 2019-07-01 |
publisher | Royan Institute (ACECR), Tehran |
record_format | Article |
series | International Journal of Fertility and Sterility |
spelling | doaj.art-b96b1ee803b8463d9af2d4abbcf6a4982022-12-21T23:09:37ZengRoyan Institute (ACECR), TehranInternational Journal of Fertility and Sterility2008-076X2008-07782019-07-0113214815310.22074/ijfs.2019.563645540Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic RatsAbbas Bakhteyari0Parvaneh Nikpour1Fatemah Sadat Mostafavi2Nahid Eskandari3Mohammad Matinfar4Sara Soleimani Asl5Roshanak Aboutorabi6Department of Anatomical Sciences, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IranDepartment of Genetics and Molecular Biology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran;Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicablDepartment of Anatomical Sciences, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran4Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran5Department of Internal Medicine Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran6Endometrium and Endometriosis Research Center, Hamedan University of Medical Sciences, Hamedan, IranDepartment of Anatomical Sciences, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IranBackground The present study was designed to evaluate serum lipid profile and tumor necrosis factor-alpha (TNF-ɑ) level in diabetic rats at implantation time. Type 2 diabetes mellitus (T2DM) could affect various systems, including innate immune system and it causes chronic low-grade inflammation, increasing level of TNF-ɑ. Furthermore, T2DM is often accompanied by impaired lipid profile. Metformin and pioglitazone are used as the first and second lines of treatment for T2DM. Materials and Methods In this experimental study, 35 adult virgin female wistar rats, weighting 175-225 g, were randomly categorized into five groups: i. Control, ii. Sham, iii. Nicotinamide (NA)+streptozotocin (STZ) induced T2DM, iv. Diabetic+pioglitazone (20 mg/kg/day for 28 days oral administration), and v. Diabetic+metformin (100 mg/kg/day for 28 days oral administration). At the time of implantation, TNF-ɑ level in serum of rats was measured by ELISA kit. Glucose was measured using photometric method and lipid profiles were calculated by enzymatic methods. Results Level of TNF-ɑ in the diabetic group was significantly higher than other groups (P < 0.001). In metformin treated group, TNF-ɑ serum level was also significantly higher than pioglitazone treated group (P < 0.001). Fasting blood sugar (FBS) and lipid profiles were significantly higher in diabetic group. Conclusion Metformin and pioglitazone have similar effects on glucose, lipid profiles and TNF-ɑ serum levels. Among these drugs, pioglitazone has more efficient influence on TNF-α serum level, in comparison with metformin.http://www.ijfs.ir/article_45540_1cd34349c0ba8a4d26e56eecb65ff422.pdfdiabetes mellitusembryo implantationmetforminpioglitazonetumor necrosis factoralpha |
spellingShingle | Abbas Bakhteyari Parvaneh Nikpour Fatemah Sadat Mostafavi Nahid Eskandari Mohammad Matinfar Sara Soleimani Asl Roshanak Aboutorabi Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats International Journal of Fertility and Sterility diabetes mellitus embryo implantation metformin pioglitazone tumor necrosis factor alpha |
title | Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats |
title_full | Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats |
title_fullStr | Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats |
title_full_unstemmed | Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats |
title_short | Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats |
title_sort | impact of metformin and pioglitazone on serum level of tumor necrosis factor alpha and lipid profiles during implantation window in diabetic rats |
topic | diabetes mellitus embryo implantation metformin pioglitazone tumor necrosis factor alpha |
url | http://www.ijfs.ir/article_45540_1cd34349c0ba8a4d26e56eecb65ff422.pdf |
work_keys_str_mv | AT abbasbakhteyari impactofmetforminandpioglitazoneonserumleveloftumornecrosisfactoralphaandlipidprofilesduringimplantationwindowindiabeticrats AT parvanehnikpour impactofmetforminandpioglitazoneonserumleveloftumornecrosisfactoralphaandlipidprofilesduringimplantationwindowindiabeticrats AT fatemahsadatmostafavi impactofmetforminandpioglitazoneonserumleveloftumornecrosisfactoralphaandlipidprofilesduringimplantationwindowindiabeticrats AT nahideskandari impactofmetforminandpioglitazoneonserumleveloftumornecrosisfactoralphaandlipidprofilesduringimplantationwindowindiabeticrats AT mohammadmatinfar impactofmetforminandpioglitazoneonserumleveloftumornecrosisfactoralphaandlipidprofilesduringimplantationwindowindiabeticrats AT sarasoleimaniasl impactofmetforminandpioglitazoneonserumleveloftumornecrosisfactoralphaandlipidprofilesduringimplantationwindowindiabeticrats AT roshanakaboutorabi impactofmetforminandpioglitazoneonserumleveloftumornecrosisfactoralphaandlipidprofilesduringimplantationwindowindiabeticrats |